GF Fund Management’s Day One Biopharmaceuticals DAWN Stock Holding History

GF Fund Management’s Portfolio DAWN Stock Details DAWN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-2,294	Closed	-$49.2K	–	604
2026 Q1	$49.2K	Buy	2,294 +277	+14%	+$3.9K	﹤0.01%	400
2025 Q4	$18.8K	Sell	2,017 -187	-8%	-$1.56K	﹤0.01%	511
2025 Q3	$15.5K	Sell	2,204 -378	-15%	-$2.6K	﹤0.01%	520
2025 Q2	$16.8K	Hold	2,582	–	–	﹤0.01%	519
2025 Q1	$20.5K	Buy	2,582 +465	+22%	+$5.01K	﹤0.01%	501
2024 Q4	$26.8K	Buy	+2,117	New	+$29.5K	﹤0.01%	446

Other funds holding DAWN

IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

GF Fund Management's DAWN Position: Q2 2026 in Review

GF Fund Management sold out of Day One Biopharmaceuticals (DAWN) in Q2 2026, closing a stake of 2,294 shares — an estimated $49.2K sold.

GF Fund Management first reported a position in DAWN in Q4 2024 and held it in 6 quarters. The position peaked at $49.2K in Q1 2026. 1 fund tracked by Wall St. Rank holds DAWN as of Q2 2026.

GF Fund Management reported no remaining Day One Biopharmaceuticals position as of Q2 2026 after selling out during the quarter.
GF Fund Management sold 2,294 Day One Biopharmaceuticals shares in Q2 2026, an estimated $49.2K.
GF Fund Management first reported a position in Day One Biopharmaceuticals in Q4 2024 and held it in 6 quarters.
GF Fund Management's Day One Biopharmaceuticals position peaked at $49.2K in Q1 2026.
1 fund tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q2 2026.

Based on GF Fund Management's 13F filing for Q2 2026, filed 7 Aug 2026.